Risk for BK viremia and nephropathy after desensitization

Transplantation

Volumn 98, Issue 2, 2014, Pages

  Sharif, Adnan ^a   Racusen, Lorraine ^b   Montgomery, Robert ^b   Kraus, Edward ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; IMMUNOGLOBULIN; RITUXIMAB;

BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PROTOCOL; DESENSITIZATION; DRUG MEGADOSE; GRAFT RECIPIENT; HIGH RISK PATIENT; HLA TYPING; HUMAN; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LETTER; LOW DRUG DOSE; PLASMAPHERESIS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; VIREMIA;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BK VIRUS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; VIREMIA;

EID: 84904574801     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000241     Document Type: Letter

References (5)

1. Barbosa D, Kahwaji J, Puliyanda D, et al. Polyomavirus BK Viremia in Kidney Transplant Recipients After Desensitization With IVIG and Rituximab. Transplantation 2014; 97: 755.
2. Sharif A, Alachkar N, Bagnasco S, et al. Incidence and outcomes of BK virus allo-graft nephropathy among ABO-and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol 2012; 7: 1320.
3. Chapman JR. Do protocol transplant biopsies improve kidney transplant outcomes? Curr Opin Nephrol Hypertens 2012; 21: 580.
4. Knight RJ, Gaber LW, Patel SJ, et al. Screening for BK viremia reduces but does not eliminate the risk for BK nephropathy: a single-center retrospective analysis. Trans-plantation 2013; 95: 949.
5. Weiss AS, Gralla J, Chan L, et al. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol 2008; 3: 1812.